<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04028947</url>
  </required_header>
  <id_info>
    <org_study_id>19-000527</org_study_id>
    <nct_id>NCT04028947</nct_id>
  </id_info>
  <brief_title>Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty</brief_title>
  <official_title>Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty: A Double-Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to determine if knee pain can be reduced by proactively protecting the
      free end of the saphenous nerve versus leaving it in the standard position during total knee
      arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects scheduled for total knee arthroplasty will be randomized to two arms. One arm will
      have the standard saphenous nerve neurectomy during their surgery. The other arm will have
      the same neurectomy procedure with the free end of the nerve tucked into soft tissue to
      protect the nerve ending.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 28, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain after surgery</measure>
    <time_frame>6 months</time_frame>
    <description>Self-reported pain using Visual Analog Scale which is scored using a horizontal scale from 0-10cm with 10 being the worst pain.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Knee Pain Chronic</condition>
  <arm_group>
    <arm_group_label>Standard TKA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will have the standard procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TKA with Neurectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will the nerve excised and protected with soft tissue.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty</intervention_name>
    <description>Prophylactic infrapatellar saphenous nerve neurectomy will be performed at the same time as the TKA.</description>
    <arm_group_label>TKA with Neurectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary unilateral total knee arthroplasty candidate

        Exclusion Criteria:

          -  Body Mass Index (BMI) &gt;40

          -  Inflammatory arthritis

          -  Unable to follow up visits (long distance from Mayo Clinic)

          -  Poor compliance risk

          -  Health condition deemed by physician to preclude patient's ability to participate in
             the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn G Shi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lori Chase, BS</last_name>
    <phone>904-953-3464</phone>
    <email>chase.lori@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>July 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Glenn G. Shi, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

